Laboratorios PiSA, S.A. de C.V. (Planta Calle 7)
⚠️ High Risk
FEI: 3005440755 • Guadalajara, Jalisco • MEXICO
FEI Number
3005440755
Location
Guadalajara, Jalisco
Country
MEXICOAddress
Calle 7 No. 1308, Col. Zona Industrial, Guadalajara, Jalisco, Mexico
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
INCONSPICU
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
UNSAFE COL
The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
COLOR LBLG
The article appears to contain an artificial coloring and it fails to bear labeling stating that fact.
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/13/2025 | 60LDP99ANALGESIC, N.E.C. | Division of Southeast Imports (DSEI) | |
| 7/2/2024 | 41GHT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Division of Southwest Imports (DSWI) |
| 5/13/2024 | 63BCE25FLUTICASONE PROPIONATE (BRONCHODILATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/13/2024 | 62FCL53MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/21/2024 | 60QAY07LIDOCAINE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/19/2024 | 60QDY07LIDOCAINE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/7/2023 | 56DCL06AMIKACIN SULFATE (AMINOGLYCOSIDES) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/7/2023 | 64LCY20DEXAMETHASONE SODIUM PHOSPHATE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/3/2023 | 60LDK69TRAMADOL HCL (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/28/2023 | 64LCK19DEXAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/7/2023 | 62GBK18DICLOFENAC SODIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/19/2022 | 66VCB99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/9/2022 | 64LDK19DEXAMETHASONE (GLUCOCORTICOID) | Division of Southeast Imports (DSEI) | |
| 10/17/2022 | 54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | Division of Southeast Imports (DSEI) | |
| 9/27/2022 | 64NCK07IRON DEXTRAN (INJ) (HEMATINIC) | Division of Southeast Imports (DSEI) | |
| 9/27/2022 | 56BCK10BENZYLPENICILLOYL-POLYLYSINE (PENICILLIN, SYNTHETICALLY PRODUCED) | Division of Southeast Imports (DSEI) | |
| 7/20/2022 | 62GCY94KETOROLAC TROMETHAMINE (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/16/2021 | 41GHT03ORAL REHYDRATION PRODUCTS | Division of Southwest Imports (DSWI) | |
| 11/30/2021 | 54ABA11HYDROXOCOBALAMIN (VITAMIN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/12/2021 | 64LDL19DEXAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/31/2021 | 41GHT03ORAL REHYDRATION PRODUCTS | Division of Southwest Imports (DSWI) | |
| 6/15/2021 | 65CDY07LEVOCARNITINE (NUTRIENT/TONIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/1/2021 | 64LDB20DEXAMETHASONE SODIUM PHOSPHATE (GLUCOCORTICOID) | 27DRUG GMPS | Division of Southeast Imports (DSEI) |
| 4/17/2020 | 64LDY19DEXAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/28/2019 | 61CCL99ANTI-ANEMIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/26/2019 | 56DDY06AMIKACIN SULFATE (AMINOGLYCOSIDES) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/16/2019 | 62GCY94KETOROLAC TROMETHAMINE (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/16/2019 | 64LCY19DEXAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/4/2017 | 65CAY07LEVOCARNITINE (NUTRIENT/TONIC) | Division of Southeast Imports (DSEI) | |
| 2/28/2017 | 61PCY55METFORMIN HCL (ANTI-DIABETIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/4/2017 | 61PCL35INSULIN HUMAN/INSULIN SUSP ISOPHANE HUMA (ANTI-DIABETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/28/2016 | 62GDK99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/29/2013 | 61PCA31GLIMEPIRIDE (ANTI-DIABETIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 3/22/2013 | 41GGT03ORAL REHYDRATION PRODUCTS | 11UNSAFE COL | Southwest Import District Office (SWI-DO) |
| 8/9/2011 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 8/9/2011 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 8/9/2011 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 8/9/2011 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 8/9/2011 | 41GGT03ORAL REHYDRATION PRODUCTS | Southwest Import District Office (SWI-DO) | |
| 11/6/2009 | 78EXGBAG, URINE COLLECTING, URETEROSTOMY | 118NOT LISTED | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Laboratorios PiSA, S.A. de C.V. (Planta Calle 7)'s FDA import refusal history?
Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) (FEI: 3005440755) has 40 FDA import refusal record(s) in our database, spanning from 11/6/2009 to 5/13/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios PiSA, S.A. de C.V. (Planta Calle 7)'s FEI number is 3005440755.
What types of violations has Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) received?
Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) come from?
All FDA import refusal data for Laboratorios PiSA, S.A. de C.V. (Planta Calle 7) is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.